DaVita Inc. 3rd Quarter 2023 Results
DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended September 30, 2023. "We delivered another strong quarter," said Javier Rodriguez, CEO of DaVita Inc. "We...
Press Releases
DaVita Unveils New Research to Drive Health Equity and Improve Care Quality during Annual American Society of Nephrology Meeting
Research includes studies designed to overcome barriers to living donation and in-home treatment among African American and Spanish-speaking Mexican American patients DENVER and PHILADELPHIA, Nov....
DaVita Inc. Schedules 3rd Quarter 2023 Investor Conference Call
DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss third quarter results on Tuesday, November 7, 2023, at 5:00 p.m. Eastern Time. The company plans...
DaVita Statement on GLP-1 and Potential Implications on Chronic Kidney Disease
DaVita issued the following statement in response to news this week from Novo Nordisk, manufacturer of Ozempic®, a glucagon-like peptide 1 (GLP-1) receptor agonist indicated for type 2 diabetes,...
DaVita launches community health tour to provide free kidney screenings and education coast-to-coast
Kidney care provider invests in early detection and prevention to help reduce progression of chronic kidney disease in key communities it serves DENVER, Sept. 13, 2023 /PRNewswire/ -- DaVita Inc....